IMEXF (Imagin Medical) Days Sales Outstanding: 0.00 (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Imagin Medical Days Sales Outstanding?

Imagin Medical IMEXF -99.00% Days Sales Outstanding is 0.00 as of Jun. 2023.

Imagin Medical's average Accounts Receivable for the three months ended in Jun. 2023 was $0.00 Mil. Imagin Medical's Revenue for the three months ended in Jun. 2023 was $0.00 Mil.

The historical rank and industry rank for Imagin Medical's Days Sales Outstanding or its related term are showing as below:

IMEXF's Days Sales Outstanding is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 65.21
* Ranked among companies with meaningful Days Sales Outstanding only.

Imagin Medical's Days Sales Outstanding stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00).

Imagin Medical  (OTCPK:IMEXF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Imagin Medical Days Sales Outstanding Related Terms

Imagin Medical Days Sales Outstanding Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Days Sales Outstanding Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMEXF vs ABT, SYK, MDT: Days Sales Outstanding Comparison

For the Medical Devices subindustry, Imagin Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imagin Medical Days Sales Outstanding vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imagin Medical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Imagin Medical's Days Sales Outstanding falls into.


Imagin Medical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Imagin Medical's Days Sales Outstanding for the fiscal year that ended in Sep. 2022 is calculated as

Days Sales Outstanding (A: Sep. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2021 ) + Accounts Receivable (A: Sep. 2022 )) / count ) / Revenue (A: Sep. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Imagin Medical's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

Days Sales Outstanding (Q: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Sales Outstanding →
What does a Days Sales Outstanding of 0.00 mean?
Imagin Medical (IMEXF) has a Days Sales Outstanding of 0.00 as of Jun. 2023. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Imagin Medical and its competitors.
Is Imagin Medical's Days Sales Outstanding too high?
Imagin Medical's current Days Sales Outstanding is 0.00.
How does Imagin Medical's Days Sales Outstanding compare to ABT and SYK?
Imagin Medical's Days Sales Outstanding of 0.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Sales Outstanding is 65.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.21, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Imagin Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imagin Medical's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current Days Sales Outstanding is 0.00 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.